BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Nottingham's SIAM & IMA Student Chapter - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:University of Nottingham's SIAM & IMA Student Chapter
X-ORIGINAL-URL:https://nottingham-siam-ima.com
X-WR-CALDESC:Events for University of Nottingham's SIAM & IMA Student Chapter
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260204T130000
DTEND;TZID=UTC:20260204T140000
DTSTAMP:20260417T050627
CREATED:20260112T191031Z
LAST-MODIFIED:20260302T114709Z
UID:706-1770210000-1770213600@nottingham-siam-ima.com
SUMMARY:Mathematics in Drug Development with Linnéa Franssen
DESCRIPTION:Linnéa Franssen\, Principal Modeling and Simulation Scientist at Roche\, is joining us to share personal reflections and suggestions regarding opportunities to enter the pharmaceutical industry from academia as a modeller. \n\n\n\nLinnéa holds a PhD in Mathematical Oncology from the University of St Andrews\, following an MSci in Mathematics at the University of Glasgow. She joined Roche as a Postdoc in 2020\, where she developed approaches to predict immunogenicity of therapeutic proteins. Transitioning to a permanent Scientist position in 2022\, she supports protein therapeutic drug development through model-based predictions that e.g. support the optimization of drug dosing schedules for First-in Human dosing or enable selecting lead drug candidates. \n\n\n\nLinkedIn post of the event: https://tinyurl.com/5xwmh5y6
URL:https://nottingham-siam-ima.com/event/mathematics-in-drug-development-with-linnea-franssen/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260225T150000
DTEND;TZID=UTC:20260225T160000
DTSTAMP:20260417T050627
CREATED:20251212T190039Z
LAST-MODIFIED:20260302T114335Z
UID:695-1772031600-1772035200@nottingham-siam-ima.com
SUMMARY:Maths Beyond Academia: Data Science & Consulting with DAMSL
DESCRIPTION:Richard Wilkinson and Theo Kypraios are Professors of Statistics at University of Nottingham. \n\n\n\nIn 2017\, Theo\, Richard and 3 other UoN colleagues founded DAMSL\, a datascience consultancy that works with clients from industry and the publicsector to help them extract value from their data. Their clients includeNetwork Rail\, the Scottish Fire and Rescue Service\, SC Johnson\, Bootsand many others.
URL:https://nottingham-siam-ima.com/event/maths-beyond-academia-data-science-consulting-with-damsl/
LOCATION:Sir Clive Granger Building A31
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260320T150000
DTEND;TZID=UTC:20260320T160000
DTSTAMP:20260417T050627
CREATED:20251217T132537Z
LAST-MODIFIED:20260310T120202Z
UID:697-1774018800-1774022400@nottingham-siam-ima.com
SUMMARY:Streamlining global drug testing by modelling side effects of drugs on the heart
DESCRIPTION:Gary Mirams is a Professor of Mathematical Physiology at the University of Nottingham. Gary and his team at the Centre for Mathematical Medicine & Biology work on modelling cardiac electrical activity. They collaborate with pharmaceutical companies such as GSK and Roche\, as well as their regulators\, and use simulations of drug effects on heart cells to predict potential side effects before human clinical trials. In his talk\, Gary will share his journey in translating academic research into real-world impact.
URL:https://nottingham-siam-ima.com/event/modelling-adverse-side-effects-of-drugs-on-the-heart/
LOCATION:Sir Clive Granger Building A31\, and online
END:VEVENT
END:VCALENDAR